doxazosin has been researched along with fibrinogen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Brusletto, B; Daae, LN; Holme, I; Kierulf, P; Syvertsen, JO; Westheim, A | 2 |
Alarayyed, NA; Betteridge, DJ; Cooper, MB; Prichard, BN; Smith, CC | 1 |
Czopf, L; Halmosi, R; Juricskay, I; Kapronczay, P; Kesmarky, G; Nemes, J; Papp, E; Toth, K; Vekasi, J | 1 |
Cui, C; Guan, M; Wang, C; Zhang, S | 1 |
5 other study(ies) available for doxazosin and fibrinogen
Article | Year |
---|---|
[The effect of doxazosin on blood pressure, lipids, fibrinogen and plasminogen activator inhibitor. A comparative study among smokers and non-smokers with essential hypertension].
Topics: Adult; Blood Pressure; Doxazosin; Fibrinogen; Humans; Hypertension; Lipids; Middle Aged; Plasminogen Inactivators; Prazosin; Smoking | 1991 |
Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
Topics: Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Fibrinogen; Hemodynamics; Humans; Hypertension; Lipids; Male; Middle Aged; Plasminogen Inactivators; Prazosin; Smoking | 1990 |
In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Aequorin; Analysis of Variance; Blood Platelets; Calcium; Calcium Channel Blockers; Collagen; Dose-Response Relationship, Drug; Doxazosin; Drug Interactions; Epinephrine; Fibrinogen; Humans; In Vitro Techniques; Luminescent Measurements; Middle Aged; Naphthalenes; Nifedipine; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors | 1997 |
Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Blood Viscosity; Doxazosin; Female; Fibrinogen; Hematocrit; Hemorheology; Humans; Hypertension; Lipids; Male; Middle Aged | 1999 |
Case Report: A 65-year-old man with paraganglioma accompanied by elevated interleukin-6 levels and KIF1B single gene mutation.
Topics: Aged; Doxazosin; Fibrinogen; Humans; Interleukin-6; Kinesins; Male; Mutation; Paraganglioma; Positron Emission Tomography Computed Tomography | 2023 |